Life update: So excited to share that I’ll be returning to Philly & joining faculty at @PennMedicine as a Classical Hematologist this summer!
@Penn is where I first learned about heme & where I realized I wanted to be a classical hematologist one day! Time to pay it forward!
Health needs don’t stop at incarceration or after release.
This month’s Hemetalks guest Dr. Michael DeBaun discusses how mass incarceration affects health care access and outcomes, including challenges providers face when caring for incarcerated patients: https://t.co/uTNNIKPwML
Very excited for our friends @OncBrothers for this amazing partnership with @OpenEvidence!
So much of hematology and oncology is the art of medicine.
Grateful to Rahul, Rohit and OpenEvidence to be able to share some of my takes through this exciting opportunity
Yes… it’s true!
We are excited to share that we have partnered with @OpenEvidence so expert quotes & practices can be shared in the right context… especially where data is limited.
It’s not AI vs us, but how we incorporate these tools together to deliver better care in community settings!
#OncTwitter #HemeTwitter @TravisZack2@VivHo@OncoAlert@OncUpdates@WilmotCancer@RoswellPark
Yes… it’s true!
We are excited to share that we have partnered with @OpenEvidence so expert quotes & practices can be shared in the right context… especially where data is limited.
It’s not AI vs us, but how we incorporate these tools together to deliver better care in community settings!
#OncTwitter #HemeTwitter @TravisZack2@VivHo@OncoAlert@OncUpdates@WilmotCancer@RoswellPark
#ICYMI the @ASH_hematology Annual Meeting is around the corner! If you're a trainee who may be attending for the first time, big conferences can seem overwhelming.
In this week's ep., we again team up with the #ASH Trainee Council to chat about how best to navigate the meeting!
Today, we continue our #PancreaticCancer journey, focusing on metastatic pancreatic cancer.
This is an area with HUGE recent advances in therapy. We discuss this and more in today' episode.
Link in bio!
Today, we hosted our first clinic Lunch and Learn!
The goal: educate our access center staff, front desk staff, medical assistants, and administrators more about what we treat and importantly why THEY matter as part of the care team.
Amazing discussion and questions!
Join us & @OncBrothers Dec 11 in New Orleans 8AM-12PM for a complimentary high yield interactive board review session on malignant & classical heme topics right before #ASHapalooza
Followed by a special career panel with our friend @rmistry91 from the @thefellowoncall🩸#ASH26
Today, in our #PancreaticCancer series, we move to borderline resectable and locally advanced disease. What does "borderline resectable" mean? What is the role for chemo and/or radiation? We discuss this and more.
Link in bio!
Adding this episode to my patient resources for #ITP! Barbara is a wealth of knowledge from 60+ years of living with ITP
Definitely check this episode out!
Remember there's a person behind the platelet count.🩸 #ITP patient advocate Barbara Pruitt shares her story, and some important reminders for hematologists, in the new HemeTalks.
🎧Listen https://t.co/ZwRBNbA3hi @rmistry91@PDSA_ITP
This episode was supported by @sanofi.
Thank you @OncBrothers for inviting me for another rapid review of one of our most common consult questions- thrombocytopenia!
Be sure to check this episode out! It’s always a great time with Rahul and Rohit
Rapid Fire Rounds (where we address 10-12 pin pointed clinical questions/cases from the community). Here is our discussion on #Thrombocytopenia w/ @rmistry91
Full 🗣️:
⭐️ https://t.co/eVd5TSMhrT
⭐️ Also on “Oncology Brothers” podcast
@OncUpdates#OncTwitter#HemeTwitter
Today, we kick off our #PancreaticCancer series, starting with the fundamentals of biology, diagnosis, and staging.
With new advances in this space, we are hopeful that the trajectory of this deadly disease will change.
This is a series you don't want to miss!
Link in bio
A common question I see in clinical practice- how to diagnose IDA in a patient who is inflamed - here is some guidance thanks @ASH_hematology updated guidelines:
- ferritin <100 OR tsat <20
- draw tsat in a fasting state for 5-9 hrs without recent supplements
#ICYMI: Updated @ASH_hematology iron deficiency (ID) guidelines are here!
ID remains one of the most common hematologic issues, yet frequently goes unrecognized & under-treated. With these updated recs, let’s change that! Our patients deserve it.
Link: https://t.co/sXUJzGXtWa
F/U to my post 👇
Check out this week’s episode of #HemeTalks where we interview my longtime mentor, colleague, friend, boss, and world renowned hematologist, and first-author of these guidelines, Dr. Adam Cuker!
Link: https://t.co/6eafwSziWL
@PennCancer@ASH_hematology
#ICYMI: the long-awaited updated @ASH_hematology#ITP guidelines are here!
With so many new agents for managing ITP, I’m excited for these recs to better help our patients achieve durable platelet responses and improved QOL
Link: https://t.co/QY57AsYnBE
In the new HemeTalks, Dr. Adam DuVall @AyaOncologist shares practical, current guidance on B-ALL. Explore treatment approaches for newly diagnosed and relapsed/refractory disease and compare approved CAR-T therapies.
🎧Listen https://t.co/ZTjiUUhjxP
#Hematology
An amazing conversation! Even if you don’t treat head and neck cancer but struggle to describe RT to your patients, @drdavidpalma’s analogies are great and can make these conversations easier
This week, we welcome Expert Rad Oncologist Dr. David Palma @drdavidpalma (@WesternU, SABR-COMET PI) to our show for our HNC series!
Rad planning, ?de-escalation, post-tx PET pitfalls, protons vs. photons, & oligometastatic disease. AND SO many amazing analogies!
Link in bio!
#ICYMI: the long-awaited updated @ASH_hematology#ITP guidelines are here!
With so many new agents for managing ITP, I’m excited for these recs to better help our patients achieve durable platelet responses and improved QOL
Link: https://t.co/QY57AsYnBE